Get informed when a big investor buys or sells
+ FollowOvervalued by 114.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.40 Trillion |
|---|---|
| Enterprise Value | $1.40 Trillion |
| Earnings per Share | $-44.07 |
| Beta | 0.81 |
| Outstanding Shares | 64,435,056 |
| P/E Ratio | -518.18 |
|---|---|
| PEG | 11266.11 |
| Price to Sales | 69.18 |
| Price to Book Ratio | 22.54 |
| Enterprise Value to Revenue | 68.36 |
| Enterprise Value to EBIT | -400.49 |
| Enterprise Value to Net Income | -518 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.32 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Headquartered in Seoul, South Korea, NatureCell Co.,Ltd. operates globally, manufacturing and distributing a diverse range of products alongside specialized services. The company's consumer goods portfolio includes canned and health-enha...